Tuesday, 02 September 2014
1 - 3 October 2014, Bad Hofgastein, Austria.
Six cutting-edge projects are in the running for the prestigious €10,000 European
Health Award 2014, sponsored by the Austrian Federal Ministry of Health and
FOPI, which brings together Austria's research-based pharmaceutical and
biotechnology companies. The winner will be chosen by a panel of leading health
experts, and announced during the 17th EHFG Conference, being held in the
Gastein Valley.
The 2014 short-list in detail
1. ITAREPS (Information Technology Aided
Relapse Prevention Programme in Schizophrenia)
https://www.itareps.com
https://www.itareps.com
The ITAREPS system (Information Technology Aided Relapse Prevention
Programme in Schizophrenia) represents a mobile phone-based e-Health solution
for weekly remote patient monitoring and disease management in schizophrenia
and psychotic disorders in general. ITAREPS provides health professionals with
home telemonitoring via a PC-to-phone SMS platform that identifies prodromal
symptoms of relapse, to enable early intervention and prevent hospitalisations.
The participants of the programme are patients and their family members. The
programme was developed by the Prague Psychiatric Centre in 2005. Based on
available evidence, ITAREPS is capable of reducing the risk of
rehospitalisation down to one-fifth.
Participating countries: Czech Republic, Slovak Republic and Japan.
2. SALUS (Scalable, Standard based
Interoperability Framework for Sustainable Pro-active Post Market Safety
Studies)
http://www.salusproject.eu
http://www.salusproject.eu
The main aim of SALUS is to complement on-going medical drug safety
studies through a scalable and standard based interoperability framework which
specially focuses on postmarketingpharmacovigilance activities. Post-marketing
pharmacovigilance can be defined as the science of detecting, assessing,
understanding, and preventing adverse effects of drugs or other drug related
problems once the drug is on market. The SALUS project fosters the integration
of clinical care information from electronic health records (EHRs) into
clinical research systems to enable proactive post-marketing safety studies for
early detection of potential safety issues.
Participating countries: Italy and Germany and partners from
Switzerland, France, Sweden, Belgium, The Netherlands and Turkey.
ExplainTB is a crowd charity project that offers free educational videos
in several languages at the point of care: more than 300 volunteers worldwide
contributed content, translations, proof-readings, voice-overs or acted as
doctors in the films. The app allows the display of movies and written
information in about 28 languages. The audio-visual content also teaches
populations that are out of reach for print material. ExplainTB helps the
healthcare worker to overcome the language barrier, allows patients to learn
about their disease in their mother tongue and provides relatives with
essential information about prevention of transmission. Furthermore, ExplainTB
allows governments to publish national guidelines and country-specific
information on a mobile point-of-care platform. Access to all videos can be
gained via an app or by scanning a QR code from a poster. The posters are
available on www.explaintb.org. The website allows the
creation of bi-lingual handouts with individually tailored written information.
Available since November 2013, ExplainTB has registered access to its website
from over 80 countries. More than 2500 regular users access the information.
Participating countries: Not applicable, videos in 16 languages, written
material in 33 languages, 12000 visitors registered from over 80 countries.
The EpiSouth-plus Project aimed at increasing health security in the
Mediterranean Area and Balkans by enhancing preparedness to threats, which can
affect health security, and to bio-security risks at national/regional levels
in the framework of International Health Regulation implementation. Building
upon the Network of 27 EU and non-EU Countries established by the previous
project EpiSouth (2006-2010), the whole initiative has lasted more than seven
years (2006-2014). The EpiSouth plus project has strengthened countries'
capacity to cope with health threats through concerted and coordinated capacity
building activities, including the establishment of a Mediterranean Regional
Laboratories network; promotion of common procedures in interoperable Generic
Preparedness and Risk management among the countries involved in the Network;
enhancement of Mediterranean Early Warning Systems (EWS) allowing alerts and
Epidemic Intelligence (EI) information sharing among EpiSouth countries and
developing interoperability with other Early Warning Systems, including the
European EWRS. Besides several trainings and workshops for epidemiologists and
lab staff, among the main outcomes of the project have been guidelines for the
establishment of lab networks and a tool for the development or the upgrading
of National Generic Emergency Preparedness Plans (EPREP).
Participating countries: Bulgaria, Cyprus,Croatia, France, Greece,
Italy, Malta, Romania, Slovenia, Spain plus 17 non-EU MS of the Mediterranean
Area and South-East Europe (Albania, Algeria, Bosnia and Herzegovina, Egypt,
FYROM, Israel, Jordan, Kosovo, Lebanon, Libya, Morocco, Montenegro, Palestine,
Serbia, Syria, Tunisia, and Turkey).
The Euro-Peristat project's aim is to develop a high quality,
innovative, internationally recognized and sustainable European perinatal
health information system, producing data and analysis on a regular basis for
use by stakeholders including clinicians (obstetricians, neonatologists,
midwives, and neonatal nurses), policy makers in health ministries, maternal
and child protection offices, and insurance and quality assurance agencies as
well as pregnant women and their families. The project began as part of the
EU's Health Monitoring Programme and relies on an active network of European
perinatal health professionals (clinicians, epidemiologists, and
statisticians). Euro-Peristat's data serve as evidence for key stakeholders
making decisions about mothers and babies´ health in Europe. Each of their
reports has been downloaded over 3000 times and in a web evaluation of 100
high-level stakeholders, 80% of respondents rated their publications very
useful for their work. Over 200 news articles have been published on their
results which have generated multiple debates about care provision to mothers
and children.
Participating countries: Twenty-nine countries currently participate in
Euro-Peristat, including the 26 EU member states and Iceland, Norway, and
Switzerland.
Electrical heart disease leading to arrhythmias represents a major
public health issue because it increases the risk for sudden cardiac death
(SCD). Current SCD prevention strategies are not directed at the underlying
risk mechanisms. The EUTrigTreat project elucidates molecular and environmental
mechanisms, which underlie life-threatening cardiac arrhythmias, and how genes
and external factors modulate and initiate catastrophic electrical
abnormalities in the heart. Improved understanding of key arrhythmia mechanisms
enables EUTrigTreat investigators to develop mechanism-targeted diagnostic and
therapeutic approaches including novel drug and device therapies. These
important objectives are investigated by a multidisciplinary research team
including clinical and basic scientists together with small-to-medium
enterprises, and through a coordinated large-scale collaborative excellence
project.
Participating countries: Belgium, France, Germany, Greece, Italy, The
Netherlands, Switzerland, U.K. and USA
Source : eHealthNews.eu
Keine Kommentare:
Kommentar veröffentlichen